Caitlin Roberts

Stock Analyst at Canaccord Genuity

(2.97)
# 2,413
Out of 5,051 analysts
150
Total ratings
43.5%
Success rate
3.4%
Average return

Stocks Rated by Caitlin Roberts

Stryker
Oct 13, 2026
Reiterated: Buy
Price Target: $385
Current: $282.55
Upside: +36.26%
Establishment Labs Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $105
Current: $58.45
Upside: +79.64%
Axogen
Oct 5, 2026
Reiterated: Buy
Price Target: $55
Current: $36.17
Upside: +52.06%
SI-BONE
Sep 29, 2026
Reiterated: Buy
Price Target: $27
Current: $19.68
Upside: +37.20%
Smith & Nephew
Sep 23, 2026
Reiterated: Hold
Price Target: $30
Current: $27.86
Upside: +7.68%
Enovis
Sep 1, 2026
Reiterated: Buy
Price Target: $45
Current: $18.99
Upside: +136.97%
Orthofix Medical
Aug 31, 2026
Reiterated: Buy
Price Target: $13
Current: $9.26
Upside: +40.39%
TELA Bio
Aug 31, 2026
Reiterated: Buy
Price Target: $2
Current: $1.07
Upside: +87.79%
Globus Medical
Aug 28, 2026
Reiterated: Buy
Price Target: $115
Current: $76.32
Upside: +50.68%
Bioventus
Aug 17, 2026
Reiterated: Buy
Price Target: $15 → $19
Current: $13.56
Upside: +40.12%
Reiterated: Hold
Price Target: $15
Current: $14.31
Upside: +4.86%
Reiterated: Buy
Price Target: $28
Current: $21.93
Upside: +27.68%
Reiterated: Buy
Price Target: $6
Current: $3.00
Upside: +100.00%
Reiterated: Buy
Price Target: $83 → $100
Current: $92.08
Upside: +8.60%
Reiterated: Buy
Price Target: $58
Current: $40.30
Upside: +43.92%
Reiterated: Buy
Price Target: $25 → $23
Current: $10.82
Upside: +112.57%